These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting. Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712 [TBL] [Abstract][Full Text] [Related]
6. An adverse drug reaction reporting system as an integral part of a drug-usage evaluation program. Saltiel E; Shane R Top Hosp Pharm Manage; 1991 Jul; 11(2):51-8. PubMed ID: 10128635 [TBL] [Abstract][Full Text] [Related]
7. Updating the French method for the causality assessment of adverse drug reactions. Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB; Therapie; 2013; 68(2):69-76. PubMed ID: 23773347 [TBL] [Abstract][Full Text] [Related]
8. [Drug-induced cutaneous photosensitivity. Results of a consensus meeting]. Roujeau JC; Beani JC; Dubertret L; Guillaume JC; Jeanmougin M; Danan G; Lagier G; Benichou C Therapie; 1989; 44(3):223-7. PubMed ID: 2528839 [TBL] [Abstract][Full Text] [Related]
9. Standardized assessment of adverse drug reactions: the method used in France. Special workshop--clinical. Begaud B Drug Inf J; 1984; 18(3-4):275-81. PubMed ID: 10268556 [TBL] [Abstract][Full Text] [Related]
10. [Will France ever have a radio-vigilance office?]. Perrot JL; Beyens MN; Vallard A; Magné N; Cinotti E Bull Cancer; 2019 Dec; 106(12):1067-1069. PubMed ID: 31350014 [No Abstract] [Full Text] [Related]
11. [Drug-induced pneumopathies (excluding cytostatic drugs)]. Akoun G; Milleron B; Mayaud C Ann Med Interne (Paris); 1989; 140(7):593-6. PubMed ID: 2610452 [TBL] [Abstract][Full Text] [Related]
12. [The French pharmacovigilance system: structure and missions]. Welsch M; Alt M; Richard MH; Imbs JL Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040 [TBL] [Abstract][Full Text] [Related]
13. [Organization and results of drug vigilance in France]. Bégaud B; Chaslerie A; Haramburu F Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001 [TBL] [Abstract][Full Text] [Related]
14. Causality assessment in pharmacovigilance: The French method and its successive updates. Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836 [TBL] [Abstract][Full Text] [Related]
16. Criteria of drug-induced liver disorders. Report of an international consensus meeting. Bénichou C J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635 [TBL] [Abstract][Full Text] [Related]
17. The detection of adverse reactions to therapeutic drugs. Finney DJ Stat Med; 1982; 1(2):153-61. PubMed ID: 7187090 [TBL] [Abstract][Full Text] [Related]
18. [French system of drug surveillance]. Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332 [TBL] [Abstract][Full Text] [Related]